The mouse as a model to investigate sex steroid metabolism in the normal and pathological prostate

Journal of Steroid Biochemistry and Molecular Biology

Volumn 131, Issue 3-5, 2012, Pages 107-121

  McNamara, Keely M ^a   Handelsman, David J ^a   Simanainen, Ulla ^a  

^a ANZAC RESEARCH INSTITUTE   (Australia)

Author keywords

Mouse; Prostate; Steroid metabolism

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; 3ALPHA HYDROXYSTEROID DEHYDROGENASE; ANDROGEN; ANDROSTENEDIONE; AROMATASE; CELL NUCLEUS RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; PROGESTERONE; PROGESTERONE RECEPTOR; SEX HORMONE; STEROID 5ALPHA REDUCTASE; STEROID RECEPTOR; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE;

CELL PROLIFERATION; ESTROGEN METABOLISM; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSIVE ELEMENT; HUMAN; KNOCKOUT MOUSE; NONHUMAN; PROGESTERONE METABOLISM; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; REVIEW; RODENT; SIGNAL TRANSDUCTION; STEROID METABOLISM; STEROIDOGENESIS;

ANDROGENS; ANIMALS; DISEASE MODELS, ANIMAL; GONADAL STEROID HORMONES; HUMANS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NEOPLASM PROTEINS; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, STEROID;

RODENTIA;

EID: 84862861767     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2011.10.009     Document Type: Review

References (227)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray, and M.J. Thun Cancer statistics 2008, CA Cancer J. Clin. 58 2 2008 71 96
2. N.W. Clarke Management of the spectrum of hormone refractory prostate cancer Eur. Urol. 50 3 2006 428 438 discussion 438-429
3. C. Huggins, and C.V. Hodges Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate 1941 J. Urol. 168 1 2002 9 12
4. A. Latil, I. Bieche, D. Vidaud, R. Lidereau, P. Berthon, O. Cussenot, and M. Vidaud Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays Cancer Res. 61 5 2001 1919 1926
5. A.N. Vis, and F.H. Schroder Key targets of hormonal treatment of prostate cancer. Part 1. The androgen receptor and steroidogenic pathways BJU Int. 104 4 2009 438 448
6. G. Attard, A.H. Reid, R. A'Hern, C. Parker, N.B. Oommen, E. Folkerd, C. Messiou, L.R. Molife, G. Maier, E. Thompson, D. Olmos, R. Sinha, G. Lee, M. Dowsett, S.B. Kaye, D. Dearnaley, T. Kheoh, A. Molina, and J.S. de Bono Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer J. Clin. Oncol. 27 23 2009 3742 3748
7. A.W. Roddam, N.E. Allen, P. Appleby, and T.J. Key Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies J. Natl. Cancer Inst. 100 3 2008 170 183
8. J.A. Locke, E.S. Guns, A.A. Lubik, H.H. Adomat, S.C. Hendy, C.A. Wood, S.L. Ettinger, M.E. Gleave, and C.C. Nelson Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer Cancer Res. 68 15 2008 6407 6415
9. U. Simanainen, C.M. Allan, P. Lim, S. McPherson, M. Jimenez, J.D. Zajac, R.A. Davey, and D.J. Handelsman Disruption of prostate epithelial androgen receptor impedes prostate lobe-specific growth and function Endocrinology 148 5 2007 2264 2272
10. U. Simanainen, K. McNamara, Y.R. Gao, and D.J. Handelsman Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation Am. J. Physiol. Endocrinol. Metab. 296 6 2009 E1335 E1343
11. Y. Niu, S. Altuwaijri, K.P. Lai, C.T. Wu, W.A. Ricke, E.M. Messing, J. Yao, S. Yeh, and C. Chang Androgen receptor is a tumor suppressor and proliferator in prostate cancer Proc. Natl. Acad. Sci. U.S.A. 105 34 2008 12182 12187
12. G. Pelletier, V. Luu-The, S. Li, J. Ouellet, and F. Labrie Cellular localization of mRNA expression of enzymes involved in the formation and inactivation of hormonal steroids in the mouse prostate J. Histochem. Cytochem. 52 10 2004 1351 1356
13. G. Pelletier Expression of steroidogenic enzymes and sex-steroid receptors in human prostate Best Pract. Res. Clin. Endocrinol. Metab. 22 2 2008 223 228
14. N. Hayashi, Y. Sugimura, J. Kawamura, A.A. Donjacour, and G.R. Cunha Morphological and functional heterogeneity in the rat prostatic gland Biol. Reprod. 45 2 1991 308 321
15. J.E. McNeal Normal histology of the prostate Am. J. Surg. Pathol. 12 8 1988 619 633
16. P. Roy-Burman, H. Wu, W.C. Powell, J. Hagenkord, and M.B. Cohen Genetically defined mouse models that mimic natural aspects of human prostate cancer development Endocr. Relat. Cancer 11 2 2004 225 254
17. N. Greenberg, F. DeMayo, M. Finegold, D. Medina, W. Tilley, J. Aspinall, G. Cunha, A. Donjacour, R. Matusik, and J. Rosen Prostate cancer in a transgenic mouse Proc. Natl. Acad. Sci. U.S.A. 92 1995 3439 3443
18. G.P. Risbridger, H. Wang, M. Frydenberg, and G.R. Cunha The metaplastic effects of estrogen on mouse prostate epithelium: proliferation of cells with basal cell phenotype Endocrinology 142 2001 2443 2450
19. A. Kirschenbaum, X.H. Liu, S. Yao, G. Narla, S.L. Friedman, J.A. Martignetti, and A.C. Levine Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones Carcinogenesis 27 2 2006 216 224
20. L. van der Heul-Nieuwenhuijsen, P.J.M. Hendriksen, T.H. van der Kwast, and G. Jenster Gene expression profiling of the human prostate zones BJU Int. 98 4 2006 886 897
21. T. Tsurusaki, D. Aoki, H. Kanetake, S. Inoue, M. Muramatsu, Y. Hiskikawa, and T. Koji Zone-dependent expression of estrogen receptors alpha and beta in human benign prostatic hyperplasia J. Clin. Endocrinol. Metab. 88 3 2003 1333 1340
22. J. Yan, and T.R. Brown Cell proliferation and expression of cell cycle regulatory proteins that control the G1/S transition are age dependent and lobe specific in the Brown Norway rat model of prostatic hyperplasia Endocrinology 149 1 2008 193 207
23. J.J. Bianco, D.J. Handelsman, J.S. Pedersen, and G.P. Risbridger Direct response of the murine prostate gland and seminal vesicles to estradiol Endocrinology 143 12 2002 4922 4933
24. P.C. Marker, A.A. Donjacour, R. Dahiya, and G.R. Cunha Hormonal, cellular, and molecular control of prostatic development Dev. Biol. 253 2 2003 165 174
25. Y. Wang, S.W. Hayward, M. Cao, K. Thayer, and G.R. Cunha Cell differentiation lineage in the prostate Differentiation 68 2001 270 279
26. G.R. Cunha, W. Ricke, A. Thomson, P.C. Marker, G. Risbridger, S.W. Hayward, Y.Z. Wang, A.A. Donjacour, and T. Kurita Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development J. Steroid Biochem. Mol. Biol. 92 2004 221 236
27. J. Mirosevich, N. Gao, and R.J. Matusik Expression of Foxa transcription factors in the developing and adult murine prostate Prostate 62 4 2005 339 352
28. K.G. Leong, B.E. Wang, L. Johnson, and W.Q. Gao Generation of a prostate from a single adult stem cell Nature 456 7223 2008 804 808
29. J. Orlowski, and A.F. Clark Epithelial-stromal interactions in the regulation of rat ventral prostate function: identification and characterization of pathways for androgen metabolism in isolated cell types Endocrinology 128 2 1991 872 884
30. V. Bellemare, F. Labrie, and V. Luu-The Isolation and characterization of a cDNA encoding mouse 3alpha-hydroxysteroid dehydrogenase: an androgen-inactivating enzyme selectively expressed in female tissues J. Steroid Biochem. Mol. Biol. 98 1 2006 18 24
31. X.-D. Wang, B.-E. Wang, R. Soriano, J. Zha, Z. Zhang, Z. Modrusan, G.R. Cunha, and W.-Q. Gao Expression profiling of the mouse prostate after castration and hormone replacement: implication of H-cadherin in prostate tumorigenesis Differentiation 75 3 2006 219 234
32. G. Pelletier, V. Luu-The, S. Li, L. Ren, and F. Labrie Localization of 17beta-hydroxysteroid dehydrogenase type 1 mRNA in mouse tissues J. Mol. Endocrinol. 33 2 2004 459 465
33. M.L. Moore, M.A. Teitell, Y. Kim, T. Watabe, R.E. Reiter, O.N. Witte, and P. Dubey Deletion of PSCA increases metastasis of TRAMP-induced prostate tumors without altering primary tumor formation Prostate 28 2007 28
34. J. Singh, P. Manickam, M. Shmoish, S. Natik, G. Denyer, D.J. Handelsman, D.-W. Gong, and Q. Dong Annotation of androgen dependence to human prostate cancer-associated genes by microarray analysis of mouse prostate Cancer Lett. 237 2006 298 302
35. J. Singh, and D.J. Handelsman Imprinting by neonatal sex steroids on the structure and function of the mature mouse prostate Biol. Reprod. 61 1 1999 200 208
36. L.Q. Cai, J. Imperato-McGinley, and Y.S. Zhu Regulation of prostate 5alpha-reductase-2 gene expression and prostate weight by dietary fat and caloric intake in the rat Prostate 66 7 2006 738 748
37. R.C. Agis-Balboa, G. Pinna, A. Zhubi, E. Maloku, M. Veldic, E. Costa, and A. Guidotti Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis Proc. Natl. Acad. Sci. U.S.A. 103 39 2006 14602 14607
38. C.T. Wu, S. Altuwaijri, W.A. Ricke, S.P. Huang, S. Yeh, C. Zhang, Y. Niu, M.Y. Tsai, and C. Chang Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor Proc. Natl. Acad. Sci. U.S.A. 104 31 2007 12679 12684
39. Y. Niu, S. Altuwaijri, S. Yeh, K.P. Lai, S. Yu, K.H. Chuang, S.P. Huang, H. Lardy, and C. Chang Targeting the stromal androgen receptor in primary prostate tumors at earlier stages Proc. Natl. Acad. Sci. U.S.A. 105 34 2008 12188 12193
40. C. Chubb, and C. Desjardins Steroid secretion by mouse testes perfused in vitro Am. J. Physiol. 244 6 1983 E575 E580
41. K.M. McNamara, D.T. Harwood, U. Simanainen, K.A. Walters, M. Jimenez, and D.J. Handelsman Measurement of sex steroids in murine blood and reproductive tissues by liquid chromatography tandem mass spectrometry J. Steroid Biochem. Mol. Biol. 121 3-5 2010 611 618
42. J. Taieb, B. Mathian, F. Millot, M.C. Patricot, E. Mathieu, N. Queyrel, I. Lacroix, C. Somma-Delpero, and P. Boudou Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children Clin. Chem. 49 8 2003 1381 1395
43. C. Wang, D.H. Catlin, L.M. Demers, B. Starcevic, and R.S. Swerdloff Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry J. Clin. Endocrinol. Metab. 89 2 2004 534 543
44. K. Sikaris, R.I. McLachlan, R. Kazlauskas, D. de Kretser, C.A. Holden, and D.J. Handelsman Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays J. Clin. Endocrinol. Metab. 90 11 2005 5928 5936
45. S.J. McPherson, H. Wang, M.E. Jones, J. Pedersen, T.P. Iismaa, N. Wreford, E.R. Simpson, and G.P. Risbridger Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland Endocrinology 142 6 2001 2458 2467
46. M.S. Mahendroo, K.M. Cala, D.L. Hess, and D.W. Russell Unexpected virilization in male mice lacking steroid 5 alpha-reductase enzymes Endocrinology 142 11 2001 4652 4662
47. Z. Weihua, S. Makela, L.C. Andersson, S. Salmi, S. Saji, J.I. Webster, E.V. Jensen, S. Nilsson, M. Warner, and J.A. Gustafsson A role for estrogen receptor beta in the regulation of growth of the ventral prostate Proc. Natl. Acad. Sci. U.S.A. 98 11 2001 6330 6335
48. G.G. Kuiper, B. Carlsson, K. Grandien, E. Enmark, J. Haggblad, S. Nilsson, and J.A. Gustafsson Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta Endocrinology 138 3 1997 863 870
49. D.S. Reddy, L. Venkatarangan, B. Chien, and K. Ramu A high-performance liquid chromatography-tandem mass spectrometry assay of the androgenic neurosteroid 3alpha-androstanediol (5alpha-androstane-3alpha 17beta-diol) in plasma Steroids 70 13 2005 879 885
50. M. Rauh, M. Groschl, W. Rascher, and H.G. Dorr Automated, fast and sensitive quantification of 17 alpha-hydroxy-progesterone, androstenedione and testosterone by tandem mass spectrometry with on-line extraction Steroids 71 6 2006 450 458
51. T. Nishiyama, Y. Hashimoto, and K. Takahashi The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer Clin. Cancer Res. 10 21 2004 7121 7126
52. M.O. Magnusson, and R. Sandstrom Quantitative analysis of eight testosterone metabolites using column switching and liquid chromatography/tandem mass spectrometry Rapid Commun. Mass Spectrom. 18 10 2004 1089 1094
53. Y. Shibata, K. Ito, K. Suzuki, K. Nakano, Y. Fukabori, R. Suzuki, Y. Kawabe, S. Honma, and H. Yamanaka Changes in the endocrine environment of the human prostate transition zone with aging: simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition Prostate 42 1 2000 45 55
54. M. Kaufman, and L. Pinsky The dissociation of testosterone- and 5 alpha-dihydrotestosterone-receptor complexes formed within cultured human genital skin fibroblasts J. Steroid Biochem. 18 2 1983 121 125
55. S. Yamashita Localization of estrogen and androgen receptors in male reproductive tissues of mice and rats Anat. Rec. A: Discov. Mol. Cell Evol. Biol. 279 2 2004 768 778
56. Y. Omoto, O. Imamov, M. Warner, and J.-A. Gustafsson Estrogen receptor alpha and imprinting of the neonatal mouse ventral prostate by estrogen Proc. Natl. Acad. Sci. U.S.A. 105 5 2005 1484 1489
57. A. Notini, R. Davey, J. McManus, K. Bate, and J. Zajac Genomic actions of the androgen receptor are required for normal male sexual differentiation in a mouse model J. Mol. Endocrinol. 35 2005 547 555
58. P. Philibert, F. Audran, C. Pienkowski, I. Morange, B. Kohler, E. Flori, C. Heinrich, C. Dacou-Voutetakis, M.G. Joseph, A.M. Guedj, H. Journel, A.C. Hecart-Bruna, I. Khotchali, S. Ten, P. Bouchard, F. Paris, and C. Sultan Complete androgen insensitivity syndrome is frequently due to premature stop codons in exon 1 of the androgen receptor gene: an international collaborative report of 13 new mutations Fertil. Steril. 94 2 2009 472 476
59. P.M. Holterhus, R. Werner, U. Hoppe, J. Bassler, E. Korsch, M.B. Ranke, H.G. Dörr, and O. Hiort Molecular features and clinical phenotypes in androgen insensitivity syndrome in the absence and presence of androgen receptor gene mutations J. Mol. Med. 83 2005 1005 1013
60. F.P. Zhang, M. Poutanen, J. Wilbertz, and I. Huhtaniemi Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice Mol. Endocrinol. 15 1 2001 172 183
61. R.A. Taylor, P. Cowin, J.F. Couse, K.S. Korach, and G.P. Risbridger 17beta-estradiol induces apoptosis in the developing rodent prostate independently of ERalpha or ERbeta Endocrinology 147 1 2006 191 200
62. X. Ma, A.C. Ziel-van der Made, B. Autar, H.A. van der Korput, M. Vermeij, P. van Duijn, K.B. Cleutjens, R. de Krijger, P. Krimpenfort, A. Berns, T.H. van der Kwast, and J. Trapman Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis Cancer Res. 65 13 2005 5730 5739
63. C.-L. Hsieh, Z. Xie, J. Yu, W.D. Martin, M.W. Datta, G.-J. Wu, and L.W.K. Chung Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model Prostate 67 7 2007 685 691
64. M. Stanbrough, I. Leav, P.W. Kwan, G.J. Bubley, and S.P. Balk Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium Proc. Natl. Acad. Sci. U.S.A. 98 19 2001 10823 10828
65. G.S. Prins Neonatal estrogen exposure induces lobe-specific alterations in adult rat prostate androgen receptor expression Endocrinology 130 6 1992 3703 3714
66. G.S. Prins Differential regulation of androgen receptors in the separate rat prostate lobes: androgen independent expression in the lateral lobe J. Steroid Biochem. 33 3 1989 319 326
67. G.R. Cunha, and L.W. Chung Stromal-epithelial interactions. I. Induction of prostatic phenotype in urothelium of testicular feminized (Tfm/y) mice J. Steroid Biochem. 14 12 1981 1317 1324
68. M. Welsh, L. Moffat, A. McNeilly, D. Brownstein, P.T. Saunders, R.M. Sharpe, and L.B. Smith Smooth muscle cell-specific knockout of androgen receptor: a new model for prostatic disease Endocrinology 152 9 2011 3541 3551
69. S. Yu, C.R. Yeh, Y. Niu, H.C. Chang, Y.C. Tsai, H.L. Moses, C.R. Shyr, C. Chang, and S. Yeh Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts Prostate 2011
70. S. Yu, C. Zhang, C.C. Lin, Y. Niu, K.P. Lai, H.C. Chang, S.D. Yeh, C. Chang, and S. Yeh Altered prostate epithelial development and IGF-1 signal in mice lacking the androgen receptor in stromal smooth muscle cells Prostate 71 5 2011 517 524
71. D.J. Mulholland, L.M. Tran, Y. Li, H. Cai, A. Morim, S. Wang, S. Plaisier, I.P. Garraway, J. Huang, T.G. Graeber, and H. Wu Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth Cancer Cell 19 6 2011 792 804
72. Y. Niu, J. Wang, Z. Shang, S.P. Huang, C.R. Shyr, S. Yeh, and C. Chang Increased CK5/CK8-positive intermediate cells with stromal smooth muscle cell atrophy in the mice lacking prostate epithelial androgen receptor PLoS One 6 7 2011 e20202
73. G. Han, G. Buchanan, M. Ittmann, J.M. Harris, X. Yu, F.J. Demayo, W. Tilley, and N.M. Greenberg Mutation of the androgen receptor causes oncogenic transformation of the prostate Proc. Natl. Acad. Sci. U.S.A. 102 4 2005 1151 1156
74. C. Zhu, R. Luong, M. Zhuo, D.T. Johnson, J.K. McKenney, G.R. Cunha, and Z. Sun Conditional expression of the androgen receptor induces oncogenic transformation of the mouse prostate J. Biol. Chem. 286 38 2011 33478 33488
75. K.E. Knudsen, and T.M. Penning Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer Trends Endocrinol. Metab. - TEM 21 5 2011 315 324
76. P.T. Saunders Oestrogen receptor beta (ER beta) Rev. Reprod. 3 3 1998 164 171
77. O. Imamov, A. Morani, G.-J. Shim, Y. Omoto, C. Thulin-Andersson, M. Warner, and J.-Å. Gustafsson Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate Proc. Natl. Acad. Sci. U.S.A. 101 25 2004 9375 9380
78. Z. Weihua, R. Lathe, M. Warner, and J.A. Gustafsson An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta, 17beta-diol, and CYP7B1, regulates prostate growth Proc. Natl. Acad. Sci. U.S.A. 99 21 2002 13589 13594
79. V. Guerini, D. Sau, E. Scaccianoce, P. Rusmini, P. Ciana, A. Maggi, P.G. Martini, B.S. Katzenellenbogen, L. Martini, M. Motta, and A. Poletti The androgen derivative 5alpha-androstane-3beta 17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype Cancer Res. 65 12 2005 5445 5453
80. S. Savolainen, T. Pakarainen, I. Huhtaniemi, M. Poutanen, and S. Makela Delay of postnatal maturation sensitizes the mouse prostate to testosterone-induced pronounced hyperplasia: protective role of estrogen receptor-beta Am. J. Pathol. 171 3 2007 1013 1022
81. G.S. Prins, and K.S. Korach The role of estrogens and estrogen receptors in normal prostate growth and disease Steroids 73 3 2008 233 244
82. W.Y. Chang, and G.S. Prins Estrogen receptor-beta: implications for the prostate gland Prostate 40 2 1999 115 124
83. J.H. Krege, J.B. Hodgin, J.F. Couse, E. Enmark, M. Warner, J.F. Mahler, M. Sar, K.S. Korach, J.-Å. Gustafsson, and O. Smithies Generation and reproductive phenotypes of mice lacking estrogen receptor beta Proc. Natl. Acad. Sci. U.S.A. 95 26 1998 15677 15682
84. S. Dupont, A. Krust, A. Gansmuller, A. Dierich, P. Chambon, and M. Mark Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes Development 127 19 2000 4277 4291
85. M.C. Antal, A. Krust, P. Chambon, and M. Mark Sterility and absence of histopathological defects in nonreproductive organs of a mouse ERbeta-null mutant Proc. Natl. Acad. Sci. U.S.A. 105 7 2008 2433 2438
86. S.J. McPherson, S. Hussain, P. Balanathan, S.L. Hedwards, B. Niranjan, M. Grant, U.P. Chandrasiri, R. Toivanen, Y. Wang, R.A. Taylor, and G.P. Risbridger Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated Proc. Natl. Acad. Sci. U.S.A. 107 7 2010 3123 3128
87. M.K. Lindberg, S. Moverare, S. Skrtic, H. Gao, K. Dahlman-Wright, J.A. Gustafsson, and C. Ohlsson Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice Mol. Endocrinol. 17 2 2003 203 208
88. G.S. Prins, L. Birch, J.F. Couse, I. Choi, B. Katzenellenbogen, and K.S. Korach Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alphaERKO and betaERKO mice Cancer Res. 61 2001 6089 6097
89. K. Asano, S. Maruyama, T. Usui, and N. Fujimoto Regulation of estrogen receptor alpha and beta expression by testosterone in the rat prostate gland Endocr. J. 50 3 2003 281 287
90. S. Makela, L. Strauss, G. Kuiper, E. Valve, S. Salmi, R. Santti, and J.A. Gustafsson Differential expression of estrogen receptors alpha and beta in adult rat accessory sex glands and lower urinary tract Mol. Cell. Endocrinol. 170 1-2 2000 219 229
91. P.J. Shughrue, M.V. Lane, P.J. Scrimo, and I. Merchenthaler Comparative distribution of estrogen receptor-alpha (ER-alpha) and beta (ER-beta) mRNA in the rat pituitary, gonad, and reproductive tract Steroids 63 10 1998 498 504
92. M. Chen, C.-R. Yeh, H.-C. Chang, S. Slavin, and S. Yeh Loss of epithelial estrogen receptor α inhibits estrogen stimulated prostate proliferation and squamous metaplasia via in vivo tissue selective knockout models J. Pathol. 2011 10.1002/path.2949
93. M. Chen, A. Wolfe, X. Wang, C. Chang, S. Yeh, and S. Radovick Generation and characterization of a complete null estrogen receptor alpha mouse using Cre/LoxP technology Mol. Cell. Biochem. 321 1-2 2009 145 153
94. Y. Omoto ER{alpha} signaling in growth of the ventral prostate: comparison of neonatal growth and post castration re-growth Endocrinology 149 9 2008 4421 4427
95. C.M. Allan, J.F. Couse, U. Simanainen, J. Spaliviero, M. Jimenez, K. Rodriguez, K.S. Korach, and D.J. Handelsman Estradiol induction of spermatogenesis is mediated via an estrogen receptor-{alpha} mechanism involving neuroendocrine activation of follicle-stimulating hormone secretion Endocrinology 151 6 2010 2800 2810
96. M. Jakacka, M. Ito, F. Martinson, T. Ishikawa, E.J. Lee, and J.L. Jameson An estrogen receptor (ER)alpha deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo Mol. Endocrinol. 16 10 2002 2188 2201
97. A. Pedram, M. Razandi, J.K. Kim, F. O'Mahony, E.Y. Lee, U. Luderer, and E.R. Levin Developmental phenotype of a membrane only estrogen receptor alpha (MOER) mouse J. Biol. Chem. 284 6 2009 3488 3495
98. K.M. Scarpin, J.D. Graham, P.A. Mote, and C.L. Clarke Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression Nucl. Recept. Signal. 7 2009 e009
99. C.M. Luetjens, A. Didolkar, S. Kliesch, W. Paulus, A. Jeibmann, W. Bocker, E. Nieschlag, and M. Simoni Tissue expression of the nuclear progesterone receptor in male non-human primates and men J. Endocrinol. 189 3 2006 529 539
100. N. Bashirelahi, J.D. Young, K. Shida, H. Yamanaka, Y. Ito, and M. Harada Androgen, estrogen, and progesterone receptors in peripheral and central zones of human prostate with adenocarcinoma Urology 21 5 1983 530 535
101. P. Robel, B. Eychenne, J.P. Blondeau, E.E. Baulieu, and O. Hechter Sex steroid receptors in normal and hyperplastic human prostate Prostate 6 3 1985 255 267
102. M. Sasaki, Y. Tanaka, G. Perinchery, A. Dharia, I. Kotcherguina, S. Fujimoto, and R. Dahiya Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer J. Natl. Cancer Inst. 94 5 2002 384 390
103. H. Bonkhoff, T. Fixemer, I. Hunsicker, and K. Remberger Progesterone receptor expression in human prostate cancer: correlation with tumor progression Prostate 48 4 2001 285 291
104. Q. Ji, P.I. Liu, Y. Elshimali, and A. Stolz Frequent loss of estrogen and progesterone receptors in human prostatic tumors determined by quantitative real-time PCR Mol. Cell. Endocrinol. 229 1-2 2005 103 110
105. M. Sasaki, Y. Tanaka, G. Perinchery, A. Dharia, I.S. Kotcherguina, i. Fujimoto, and R. Dahiya Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer J. Natl. Cancer Inst. 94 2002 384 390
106. B.M. Jacobsen, and B. Horwitz Progesterone receptors, their isoforms and progesterone regulated transcription Mol. Cell. Endocrinol. 2011 10.1016/j.mce.2011.09.016
107. J.P. Lydon, F.J. DeMayo, O.M. Conneely, and B.W. O'Malley Reproductive phenotpes of the progesterone receptor null mutant mouse J. Steroid Biochem. Mol. Biol. 56 1-6 Spec No 1996 67 77
108. J. Wang, I.E. Eltoum, and C.A. Lamartiniere Genistein chemoprevention of prostate cancer in TRAMP mice J. Carcinog. 6 3 2007 3
109. J.H. Check, E. Dix, C. Wilson, and D. Check Progesterone receptor antagonist therapy has therapeutic potential even in cancer restricted to males as evidenced from murine testicular and prostate cancer studies Anticancer Res. 30 12 2011 4921 4923
110. U. Simanainen, A. Lampinen, H. Henneicke, T.C. Brennan, U. Heinevetter, D.T. Harwood, K. McNamara, M. Herrmann, M.J. Seibel, D.J. Handelsman, and H. Zhou Long-term corticosterone treatment induced lobe-specific pathology in mouse prostate Prostate 71 3 2010 289 297
111. A. McMaster, and D.W. Ray Drug insight: selective agonists and antagonists of the glucocorticoid receptor Nat. Clin. Pract. Endocrinol. Metab. 4 2 2008 91 101
112. A. Yemelyanov, J. Czwornog, D. Chebotaev, A. Karseladze, E. Kulevitch, X. Yang, and I. Budunova Tumor suppressor activity of glucocorticoid receptor in the prostate Oncogene 26 13 2007 1885 1896
113. J.L. Mohler, Y. Chen, K. Hamil, S.H. Hall, J.A. Cidlowski, E.M. Wilson, F.S. French, and M. Sar Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma Clin. Cancer Res. 2 5 1996 889 895
114. D.M. Peehl, and D. Feldman Interaction of nuclear receptor ligands with the Vitamin D signaling pathway in prostate cancer J. Steroid Biochem. Mol. Biol. 92 4 2004 307 315
115. M. Fakih, C.S. Johnson, and D.L. Trump Glucocorticoids and treatment of prostate cancer: a preclinical and clinical review Urology 60 4 2002 553 561
116. P.W. Harvey, J. Er, C. Fernandes, K.C. Rush, I.R. Major, and A. Cockburn Corticosterone does not cause testicular toxicopathology in the rat: relevance to methylxanthines, ACTH and stress Hum. Exp. Toxicol. 11 6 1992 505 509
117. S.A. Lerman, G.K. Miller, K. Bohlman, V. Albaladejo, J.F. Leonard, V. Devas, and R.L. Clark Effects of corticosterone on reproduction in male Sprague-Dawley rats Reprod. Toxicol. 11 6 1997 799 805
118. P.S. Rennie, J.F. Bowden, S.N. Freeman, N. Bruchovsky, H. Cheng, D.B. Lubahn, E.M. Wilson, F.S. French, and L. Main Cortisol alters gene expression during involution of the rat ventral prostate Mol. Endocrinol. 3 4 1989 703 708
119. P.S. Rennie, J.F. Bowden, N. Bruchovsky, and H. Cheng The relationship between inhibition of plasminogen-activator activity and prostatic involution Biochem. J. 252 3 1988 759 764
120. S.A. Almeida, S.O. Petenusci, J.A. Anselmo-Franci, A.A. Rosa-e-Silva, and T.L. Lamano-Carvalho Decreased spermatogenic and androgenic testicular functions in adult rats submitted to immobilization-induced stress from prepuberty Braz. J. Med. Biol. Res. 31 11 1998 1443 1448
121. A. Haelens, G. Verrijdt, L. Callewaert, B. Peeters, W. Rombauts, and F. Claessens Androgen-receptor-specific DNA binding to an element in the first exon of the human secretory component gene Biochem. J. 353 Pt 3 2001 611 620
122. A.C. Cato, D. Henderson, and H. Ponta The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region EMBO J. 6 2 1987 363 368
123. J. Ham, A. Thomson, M. Needham, P. Webb, and M. Parker Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus Nucleic Acids Res. 16 12 1988 5263 5276
124. K. Umesono, and R.M. Evans Determinants of target gene specificity for steroid/thyroid hormone receptors Cell 57 7 1989 1139 1146
125. H. Gong, M.J. Jarzynka, T.J. Cole, J.H. Lee, T. Wada, B. Zhang, J. Gao, W.C. Song, D.B. DeFranco, S.Y. Cheng, and W. Xie Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase Cancer Res. 68 18 2008 7386 7393
126. J.S. Schneider, C. Burgess, N.C. Sleiter, L.L. DonCarlos, J.P. Lydon, B. O'Malley, and J.E. Levine Enhanced sexual behaviors and androgen receptor immunoreactivity in the male progesterone receptor knockout mouse Endocrinology 146 10 2005 4340 4348
127. W. Schmid, T.J. Cole, J.A. Blendy, and G. Schutz Molecular genetic analysis of glucocorticoid signalling in development J. Steroid Biochem. Mol. Biol. 53 1-6 1995 33 35
128. F. Tronche, C. Kellendonk, O. Kretz, P. Gass, K. Anlag, P.C. Orban, R. Bock, R. Klein, and G. Schutz Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety Nat. Genet. 23 1 1999 99 103
129. O. Barbier, and A. Belanger The cynomolgus monkey (Macaca fascicularis) is the best animal model for the study of steroid glucuronidation J. Steroid Biochem. Mol. Biol. 85 2-5 2003 235 245
130. A. Belanger, G. Pelletier, F. Labrie, O. Barbier, and S. Chouinard Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans Trends Endocrinol. Metab. - TEM 14 10 2003 473 479
131. P.I. Mackenzie, K.W. Bock, B. Burchell, C. Guillemette, S. Ikushiro, T. Iyanagi, J.O. Miners, I.S. Owens, and D.W. Nebert Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily Pharmacogenet. Genomics 15 10 2005 677 685
132. R.J. Auchus The backdoor pathway to dihydrotestosterone Trends Endocrinol. Metab. - TEM 15 9 2004 432 438
133. J.A. Locke, C.C. Nelson, H.H. Adomat, S.C. Hendy, M.E. Gleave, and E.S. Guns Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts J. Steroid Biochem. Mol. Biol. 115 3-5 2009 126 136
134. K.H. Chang, R. Li, M. Papari-Zareei, L. Watumull, Y.D. Zhao, R.J. Auchus, and N. Sharifi Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer Proc. Natl. Acad. Sci. U.S.A. 108 33 2011 13728 13733
135. D.M. Berman, and D.W. Russell Cell-type-specific expression of rat steroid 5 alpha-reductase isozymes Proc. Natl. Acad. Sci. U.S.A. 90 20 1993 9359 9363
136. T. Miyamoto, S. Kagawa, K. Kitagawa, S. Futaki, H. Yokoi, Y. Tsuruo, and K. Ishimura Immunocytochemical localization of 5 alpha-reductase type 1 in the prostate of normal and castrated rats Histochem. Cell Biol. 105 2 1996 101 109
137. V. Cantagrel, D.J. Lefeber, B.G. Ng, Z. Guan, J.L. Silhavy, S.L. Bielas, L. Lehle, H. Hombauer, M. Adamowicz, E. Swiezewska, A.P. De Brouwer, P. Blumel, J. Sykut-Cegielska, S. Houliston, D. Swistun, B.R. Ali, W.B. Dobyns, D. Babovic-Vuksanovic, H. van Bokhoven, R.A. Wevers, C.R. Raetz, H.H. Freeze, E. Morava, L. Al-Gazali, and J.G. Gleeson SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder Cell 142 2 2010 203 217
138. C. Iehle, F. Radvanyi, S. Gil Diez de Medina, L.H. Ouafik, H. Gerard, D. Chopin, J.P. Raynaud, and P.M. Martin Differences in steroid 5alpha-reductase iso-enzymes expression between normal and pathological human prostate tissue J. Steroid Biochem. Mol. Biol. 68 5-6 1999 189 195
139. N. Bruchovsky, M.D. Sadar, K. Akakura, S.L. Goldenberg, K. Matsuoka, and P.S. Rennie Characterization of 5alpha-reductase gene expression in stroma and epithelium of human prostate J. Steroid Biochem. Mol. Biol. 59 5-6 1996 397 404
140. M. Uemura, K. Tamura, S. Chung, S. Honma, A. Okuyama, Y. Nakamura, and H. Nakagawa Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer Cancer Sci. 99 1 2008 81 86
141. M.S. Mahendroo, and D.W. Russell Male and female isoenzymes of steroid 5alpha-reductase Rev. Reprod. 4 3 1999 179 183
142. S.A. Wright, R.C. Douglas, L.N. Thomas, C.B. Lazier, and R.S. Rittmaster Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase Endocrinology 140 10 1999 4509 4515
143. E. di Salle, D. Giudici, L. Biagini, C. Cominato, G. Briatico, and A. Panzeri Effects of 5 alpha inhibitors on intraprostatic androgen in the rat J. Steroid Biochem. Mol. Biol. 53 1-6 1995 381 385
144. Y. Jin, and T.M. Penning Steroid 5 alpha-reductases and 3 alpha hydroxysteroid dehydrogenases: key enzymes in androgen metabolism Best Pract. Res. Clin. Endocrinol. Metab. 15 1 2001 79 94
145. S. Ohsako, Y. Miyabara, N. Nishimura, S. Kurosawa, M. Sakaue, R. Ishimura, M. Sato, K. Takeda, Y. Aoki, H. Sone, C. Tohyama, and J. Yonemoto Maternal exposure to a low dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppressed the development of reproductive organs of male rats: dose-dependent increase of mRNA levels of 5alpha-reductase type 2 in contrast to decrease of androgen receptor in the pubertal ventral prostate Toxicol. Sci. 60 2001 132 143
146. K. Normington, and D.W. Russell Tissue distribution and kinetic characteristics of rat steroid 5 alpha-reductase isozymes. Evidence for distinct physiological functions J. Biol. Chem. 267 27 1992 19548 19554
147. D. Matsui, M. Sakari, T. Sato, A. Murayama, I. Takada, M. Kim, K.-i. Takeyama, and S. Kato Transcriptional regulation of the mouse steroid 5alpha-reductase type II gene by progesterone in brain Nucleic Acids Res. 30 6 2002 1387 1393
148. F.W. George, D.W. Russell, and J.D. Wilson Feed-forward control of prostate growth: dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5 alpha-reductase Proc Natl. Acad. Sci. U.S.A. 88 18 1991 8044 8047
149. R. Santti, R.R. Newbold, and J.A. McLachlan Androgen metabolism in control and neonatally estrogenized male mice Reprod. Toxicol. 5 2 1991 149 155
150. P.I. Lundmo, A. Sunde, and K.J. Tveter Metabolism of androgens in the seminal vesicles and the different lobes of the prostate in young mature rats J. Steroid Biochem. 22 4 1985 513 519
151. S. Marchais-Oberwinkler, C. Henn, G. Moller, T. Klein, M. Negri, A. Oster, A. Spadaro, R. Werth, M. Wetzel, K. Xu, M. Frotscher, R.W. Hartmann, and J. Adamski 17beta-Hydroxysteroid dehydrogenases (17beta-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development J. Steroid Biochem. Mol. Biol. 125 1-2 2011 66 82
152. G. Moeller, and J. Adamski Integrated view on 17beta-hydroxysteroid dehydrogenases Mol. Cell. Endocrinol. 301 1-2 2009 7 19
153. M.V. Mustonen, M.H. Poutanen, V.V. Isomaa, P.T. Vihko, and R.K. Vihko Cloning of mouse 17beta-hydroxysteroid dehydrogenase type 2, and analysing expression of the mRNAs for types 1, 2, 3, 4 and 5 in mouse embryos and adult tissues Biochem. J. 325 Pt 1 1997 199 205
154. J.A. Sha, K. Dudley, W.R. Rajapaksha, and P.J. O'Shaughnessy Sequence of mouse 17beta-hydroxysteroid dehydrogenase type 3 cDNA and tissue distribution of the type 1 and type 3 isoform mRNAs J. Steroid Biochem. Mol. Biol. 60 1-2 1997 19 24
155. X.-Y. He, Y.-Z. Yang, D.M. Peehl, A. Lauderdale, H. Schulz, and S.-Y. Yang Oxidative 3alpha-hydroxysteroid dehydrogenase activity of human type 10 17beta-hydroxysteroid dehydrogenase J. Steroid Biochem. Mol. Biol. 87 2003 191 198
156. B. Keller, K. Grote, and J. Adamski In silico Northern blot, an automated method to determine expression patterns from EST databases, reveals tissue specificity of murine 17beta-hydroxysteroid dehydrogenase type 11 Mol. Cell. Endocrinol. 248 1-2 2006 242 245
157. P. Nokelainen, T. Puranen, H. Peltoketo, M. Orava, P. Vihko, and R. Vihko Molecular cloning of mouse 17 beta-hydroxysteroid dehydrogenase type 1 and characterization of enzyme activity Eur. J. Biochem. 236 2 1996 482 490
158. P. Nokelainen, H. Peltoketo, R. Vihko, and P. Vihko Expression cloning of a novel estrogenic mouse 17 beta-hydroxysteroid dehydrogenase/17-ketosteroid reductase (m17HSD7), previously described as a prolactin receptor-associated protein (PRAP) in rat Mol. Endocrinol. 12 7 1998 1048 1059
159. J. Su, M. Lin, and J.L. Napoli Complementary deoxyribonucleic acid cloning and enzymatic characterization of a novel 17beta/3alpha-hydroxysteroid/ retinoid short chain dehydrogenase/reductase Endocrinology 140 11 1999 5275 5284
160. T. Normand, B. Husen, F. Leenders, H. Pelczar, J.L. Baert, A. Begue, A.C. Flourens, J. Adamski, and Y. de Launoit Molecular characterization of mouse 17 beta-hydroxysteroid dehydrogenase IV J. Steroid Biochem. Mol. Biol. 55 5-6 1995 541 548
161. Y. Deyashiki, K. Ohshima, M. Nakanishi, K. Sato, K. Matsuura, and A. Hara Molecular cloning and characterization of mouse estradiol 17 beta-dehydrogenase (A-specific), a member of the aldoketoreductase family J. Biol. Chem. 270 18 1995 10461 10467
162. J. Fomitcheva, M.E. Baker, E. Anderson, G.Y. Lee, and N. Aziz Characterization of Ke 6, a new 17beta-hydroxysteroid dehydrogenase, and its expression in gonadal tissues J. Biol. Chem. 273 35 1998 22664 22671
163. Y. Horiguchi, M. Araki, and K. Motojima 17beta-Hydroxysteroid dehydrogenase type 13 is a liver-specific lipid droplet-associated protein Biochem. Biophys. Res. Commun. 370 2 2008 235 238
164. P. Lukacik, B. Keller, G. Bunkoczi, K.L. Kavanagh, W.H. Lee, J. Adamski, and U. Oppermann Structural and biochemical characterization of human orphan DHRS10 reveals a novel cytosolic enzyme with steroid dehydrogenase activity Biochem. J. 402 3 2007 419 427
165. W.M. Geissler, D.L. Davis, L. Wu, K.D. Bradshaw, S. Patel, B.B. Mendonca, K.O. Elliston, J.D. Wilson, D.W. Russell, and S. Andersson Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydrogenase 3 Nat. Genet. 7 1 1994 34 39
166. P. Rheault, A. Charbonneau, and V. Luu-The Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1) Biochim. Biophys. Acta 1447 1 1999 17 24
167. P.G. Blanchard, and V. Luu-The Differential androgen and estrogen substrates specificity in the mouse and primates type 12 17beta-hydroxysteroid dehydrogenase J. Endocrinol. 194 2 2007 449 455
168. P.I. Lundmo, A. Sunde, and K.J. Tveter Age dependent changes in androgen metabolism in the rat prostate J. Steroid Biochem. 22 4 1985 521 528
169. L. Pylkkanen, R. Santti, O. Maentausta, and R. Vihko Distribution of estradiol-17 beta hydroxysteroid oxidoreductase in the urogenital tract of control and neonatally estrogenized male mice: immunohistochemical, enzymehistochemical, and biochemical study Prostate 20 1 1992 59 72
170. F. Leenders, J.G. Tesdorpf, M. Markus, T. Engel, U. Seedorf, and J. Adamski Porcine 80-kDa protein reveals intrinsic 17 beta-hydroxysteroid dehydrogenase, fatty acyl-CoA-hydratase/dehydrogenase, and sterol transfer activities J. Biol. Chem. 271 10 1996 5438 5442
171. M.G. Biswas, and D.W. Russell Expression cloning and characterization of oxidative 17beta- and 3alpha-hydroxysteroid dehydrogenases from rat and human prostate J. Biol. Chem. 272 25 1997 15959 15966
172. X.Y. He, G. Merz, C.H. Chu, D. Lin, Y.Z. Yang, P. Mehta, H. Schulz, and S.Y. Yang Molecular cloning, modeling, and localization of rat type 10 17beta-hydroxysteroid dehydrogenase Mol. Cell. Endocrinol. 171 1-2 2001 89 98
173. P. Brereton, T. Suzuki, H. Sasano, K. Li, C. Duarte, V. Obeyesekere, F. Haeseleer, K. Palczewski, I. Smith, P. Komesaroff, and Z. Krozowski Pan1b (17betaHSD11)-enzymatic activity and distribution in the lung Mol. Cell. Endocrinol. 171 1-2 2001 111 117
174. K.H. Lee, and P. Ofner Reductive metabolism of 5 alpha- dihydrotestosterone by rat ventral and dorsolateral prostate: kinetic parameters of the enzymes J. Steroid Biochem. 29 5 1988 553 557
175. P.A. Bain, M. Yoo, T. Clarke, S.H. Hammond, and A.H. Payne Multiple forms of mouse 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase and differential expression in gonads, adrenal glands, liver, and kidneys of both sexes Proc. Natl. Acad. Sci. U.S.A. 88 20 1991 8870 8874
176. I.G. Abbaszade, T.R. Clarke, C.H. Park, and A.H. Payne The mouse 3 beta-hydroxysteroid dehydrogenase multigene family includes two functionally distinct groups of proteins Mol. Endocrinol. 9 9 1995 1214 1222
177. I.G. Abbaszade, J. Arensburg, C.H. Park, J.Z. Kasa-Vubu, J. Orly, and A.H. Payne Isolation of a new mouse 3beta-hydroxysteroid dehydrogenase isoform 3beta-HSD VI, expressed during early pregnancy Endocrinology 138 4 1997 1392 1399
178. T.R. Clarke, P.A. Bain, T.L. Greco, and A.H. Payne A novel mouse kidney 3 beta-hydroxysteroid dehydrogenase complementary DNA encodes a 3-ketosteroid reductase instead of a 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase Mol. Endocrinol. 7 12 1993 1569 1578
179. C. Labrie, A. Belanger, and F. Labrie Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate Endocrinology 123 3 1988 1412 1417
180. K.D. Voigt, and W. Bartsch Intratissular androgens in benign prostatic hyperplasia and prostatic cancer J. Steroid Biochem. 25 5B 1986 749 757
181. J.-A. Gustafsson Steroids and the scientist Mol. Endocrinol. 19 6 2005 1412 1417
182. Q. Yang, M.A. Titus, K.M. Fung, and H.K. Lin 5alpha-androstane-3alpha, 17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression J. Cell. Biochem. 104 5 2008 1612 1624
183. S.J. Ellem, J.F. Schmitt, J.S. Pedersen, M. Frydenberg, and G.P. Risbridger Local aromatase expression in human prostate is altered in malignancy J. Clin. Endocrinol. Metab. 89 5 2004 2434 2441
184. C.R. Fisher, K.H. Graves, A.F. Parlow, and E.R. Simpson Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene Proc. Natl. Acad. Sci. U.S.A. 95 12 1998 6965 6970
185. J.J. Bianco, S.J. McPherson, H. Wang, G.S. Prins, and G.P. Risbridger Transient neonatal estrogen exposure to estrogen-deficient mice (aromatase knockout) reduces prostate weigh and induces inflammation in later life Am. J. Pathol. 168 6 2006 1869 1879
186. S.J. McPherson, S.J. Ellem, E.R. Simpson, V. Patchev, K.-H. Fritzemeier, and G.P. Risbridger Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia Endocrinology 148 2 2007 566 574
187. H. Sasano, T. Suzuki, T. Nakata, and T. Moriya New development in intracrinology of breast carcinoma Breast Cancer 13 2 2006 129 136
188. Z. Krozowski, K.X. Li, K. Koyama, R.E. Smith, V.R. Obeyesekere, A. Stein-Oakley, H. Sasano, C. Coulter, T. Cole, and K.E. Sheppard The type I and type II 11beta-hydroxysteroid dehydrogenase enzymes J. Steroid Biochem. Mol. Biol. 69 1-6 1999 391 401
189. X.L. Moore, I. Hoong, and T.J. Cole Expression of the 11beta-hydroxysteroid dehydrogenase 2 gene in the mouse Kidney Int. 57 4 2000 1307 1312
190. M.C. Holmes, Y. Kotelevtsev, J.J. Mullins, and J.R. Seckl Phenotypic analysis of mice bearing targeted deletions of 11beta-hydroxysteroid dehydrogenases 1 and 2 genes Mol. Cell. Endocrinol. 171 1-2 2001 15 20
191. F. Labrie Intracrinology Mol. Cell. Endocrinol. 78 3 1991 C113 C118
192. A. Di Cristofano, M. De Acetis, A. Koff, C. Cordon-Cardo, and P.P. Pandolfi Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse Nat. Genet. 27 2 2001 222 224
193. M.J. Kim, R.D. Cardiff, N. Desai, W.A. Banach-Petrosky, R. Parsons, M.M. Shen, and C. Abate-Shen Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis Proc. Natl. Acad. Sci. U.S.A. 99 5 2002 2884 2889
194. B. Montgomery, P.S. Nelson, R. Vessella, T. Kalhorn, D. Hess, and E. Corey Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer BMC Cancer 10 2010 244
195. V. Jeet, P.J. Russell, and A. Khatri Modeling prostate cancer: a perspective on transgenic mouse models Cancer Metastasis Rev. 29 1 2010 123 142
196. K.C. Valkenburg, and B.O. Williams Mouse models of prostate cancer Prostate Cancer 2011 2011 10.1155/2011/895238
197. J.A. Locke, L. Fazli, H. Adomat, J. Smyl, K. Weins, A.A. Lubik, D.B. Hales, C.C. Nelson, M.E. Gleave, and E.S. Tomlinson Guns A novel communication role for CYP17A1 in the progression of castration-resistant prostate cancer Prostate 69 9 2009 928 937
198. Y. Wang, T. Romigh, X. He, M.H. Tan, M.S. Orloff, R.H. Silverman, W.D. Heston, and C. Eng Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers Oncogene 30 42 2011 4327 4338
199. K. Murti, L.M. Butler, A.J. Sakko, C. Ricciardelli, T.B. Mitto, A. Octnick, J. Stahl, and W. Tilley Androgen receptor levels during progression of prostate cancer in the transgenic adenocarcinoma of mouse prostate model Med. J. Indonesia 19 1 2010 5 13
200. J.S. Diallo, A. Aldejmah, A.F. Mouhim, M.A. Fahmy, I.H. Koumakpayi, K. Sircar, L.R. Begin, A.M. Mes-Masson, and F. Saad Co-assessment of cytoplasmic and nuclear androgen receptor location in prostate specimens: potential implications for prostate cancer development and prognosis BJU Int. 101 10 2008 1302 1309
201. J.L. Thielen, K.G. Volzing, L.S. Collier, L.E. Green, D.A. Largaespada, and P.C. Marker Markers of prostate region-specific epithelial identity define anatomical locations in the mouse prostate that are molecularly similar to human prostate cancers Differentiation 75 2006 49 61
202. D. Price Comparative aspects of development and structure in the prostate Natl. Cancer Inst. Monogr. 12 1963 1 27
203. S.B. Shappell, G.V. Thomas, R.L. Roberts, R. Herbert, M.M. Ittmann, M.A. Rubin, P.A. Humphrey, J.P. Sundberg, N. Rozengurt, R. Barrios, J.M. Ward, and R.D. Cardiff Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee Cancer Res. 64 6 2004 2270 2305
204. T. Higashi, A. Yamauchi, K. Shimada, E. Koh, A. Mizokami, and M. Namiki Determination of prostatic androgens in 10 mg of tissue using liquid chromatography-tandem mass spectrometry with charged derivatization Anal. Bioanal. Chem. 382 4 2005 1035 1043
205. B. Kashiwagi, Y. Shibata, Y. Ono, R. Suzuki, S. Honma, and K. Suzuki Changes in testosterone and dihydrotestosterone levels in male rat accessory sex organs, serum, and seminal fluid after castration: establishment of a new highly sensitive simultaneous androgen measurement method J. Androl. 26 5 2005 586 591
206. V. Luu-The, A. Belanger, and F. Labrie Androgen biosynthetic pathways in the human prostate Best Pract. Res. Clin. Endocrinol. Metab. 22 2 2008 207 221
207. N. Tagawa, Y. Sugimoto, J. Yamada, and Y. Kobayashi Strain differences of neurosteroid levels in mouse brain Steroids 71 9 2006 776 784
208. F. Labrie, V. Luu-The, A. Belanger, S.X. Lin, J. Simard, G. Pelletier, and C. Labrie Is dehydroepiandrosterone a hormone? J. Endocrinol. 187 2 2005 169 196
209. I. Leav, K.M. Lau, J.Y. Adams, J.E. McNeal, M.E. Taplin, J. Wang, H. Singh, and S.M. Ho Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands dysplasia, and in primary and metastatic carcinoma [see comment] Am. J. Pathol. 159 1 2001 79 92
210. L.S. Marks 5alpha-reductase: history and clinical importance Rev. Urol. 6 Suppl. 9 2004 S11 S21
211. M.E. Gleave, J. Qian, C. Andreou, P. Pommerville, J. Chin, R. Casey, G. Steinhoff, N. Fleshner, D. Bostwick, L. Thomas, and R. Rittmaster The effects of the dual 5alpha-reductase inhibitor dutasteride on localized prostate cancer - results from a 4-month pre-radical prostatectomy study Prostate 66 15 2006 1674 1685
212. F.K. Habib, M. Ross, C.W. Bayne, K. Grigor, A.C. Buck, P. Bollina, and K. Chapman The localisation and expression of 5 alpha-reductase types I and II mRNAs in human hyperplastic prostate and in prostate primary cultures J. Endocrinol. 156 3 1998 509 517
213. M. Meier, G. Moller, and J. Adamski Perspectives in understanding the role of human 17beta-hydroxysteroid dehydrogenases in health and disease Ann. N. Y. Acad. Sci. 1155 2009 15 24
214. T.M. Penning, and M.C. Byrns Steroid hormone transforming aldo-keto reductases and cancer Ann. N. Y. Acad. Sci. 1155 2009 33 42
215. P. Velica, N.J. Davies, P.P. Rocha, H. Schrewe, J.P. Ride, and C.M. Bunce Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers Mol. Cancer 8 2009 121
216. S. Torn, P. Nokelainen, R. Kurkela, A. Pulkka, M. Menjivar, S. Ghosh, M. Coca-Prados, H. Peltoketo, V. Isomaa, and P. Vihko Production, purification, and functional analysis of recombinant human and mouse 17beta-hydroxysteroid dehydrogenase type 7 Biochem. Biophys. Res. Commun. 305 1 2003 37 45
217. J.L. Mohler, M.A. Titus, S. Bai, B.J. Kennerley, F.B. Lih, K.B. Tomer, and E.M. Wilson Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer Cancer Res. 71 4 2011 1486 1496
218. E. Koh, T. Noda, J. Kanaya, and M. Namiki Differential expression of 17beta-hydroxysteroid dehydrogenase isozyme genes in prostate cancer and noncancer tissues Prostate 53 2 2002 154 159
219. Y. Takase, M.-H. Levesque, V. Luu-The, M. El-Alfy, F. Labrie, and G. Pelletier Expression of enzymes involved in estrogen metabolism in human prostate J. Histochem. Cytochem. 54 8 2006 911 921
220. E. Kassi, and P. Moutsatsou Glucocorticoid receptor signaling and prostate cancer Cancer Lett. 302 1 2011 1 10
221. M. Nomura, L. Durbak, J. Chan, O. Smithies, J.A. Gustafsson, K.S. Korach, D.W. Pfaff, and S. Ogawa Genotype/age interactions on aggressive behavior in gonadally intact estrogen receptor beta knockout (betaERKO) male mice Horm. Behav. 41 3 2002 288 296
222. D.B. Lubahn, J.S. Moyer, T.S. Golding, J.F. Couse, K.S. Korach, and O. Smithies Alteration of reproductive funcion but not prenatal sexual development after insertional disruption of the mouse estrogen gene Proc. Natl. Acad. Sci. U.S.A. 90 1993 11162 11166
223. M. Chen, I. Hsu, A. Wolfe, S. Radovick, K. Huang, S. Yu, C. Chang, E.M. Messing, and S. Yeh Defects of prostate development and reproductive system in the estrogen receptor-{alpha} null male mice Endocrinology 150 1 2009 251 259
224. J.E. Couse, D. Mahato, E.M. Eddy, and K.S. Korach Molecular mechanism of estrogen action in the male: insights from the estrogen receptor null mice Reprod. Fertil. Dev. 13 4 2001 211 219
225. E.M. Eddy, T.F. Washburn, D.O. Bunch, E.H. Goulding, B.C. Gladen, D.B. Lubahn, and K.S. Korach Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility Endocrinology 137 11 1996 4796 4805
226. V. Luu-The, G. Pelletier, and F. Labrie Quantitative appreciation of steroidogenic gene expression in mouse tissues: new roles for type 2 5alpha-reductase, 20alpha-hydroxysteroid dehydrogenase and estrogen sulfotransferase J. Steroid Biochem. Mol. Biol. 93 2-5 2005 269 276
227. U. Simanainen, K. McNamara, Y.R. Gao, S. McPherson, R. Desai, M. Jimenez, and D.J. Handelsman Anterior prostate epithelial AR inactivation modifies estrogen receptor expression and increases estrogen sensitivity Am. J. Physiol. Endocrinol. Metab. 301 4 2011 E727 E735